A PHASE 2, 16-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY AND EFFICACY OF REPEATED DOSES OF KB001-A IN SUBJECTS INFECTED WITH P. AERUGINOSA

被引：0

作者：

Chmiel, J. ^{[1
]}

Hamblett, N. M. ^{[2
]}

Geller, D. ^{[3
]}

Konstan, M. ^{[1
]}

VanDevanter, D. ^{[1
]}

Thompson, V ^{[2
]}

Molfino, N. ^{[3
]}

Yarranton, G. ^{[3
]}

Shreeniwas, R. ^{[3
]}

机构：

[1] Case Western Reserve Univ, Cleveland, OH 44106 USA

[2] Seattle Childrens Hosp, Seattle, WA USA

[3] KaloBios Pharmaceut Inc, San Francisco, CA USA

来源：

PEDIATRIC PULMONOLOGY | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

218

引用

页码：272 / 272

页数：1

共 50 条

[41] Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
Mollace, Rocco
Gliozzi, Micaela
Macri, Roberta
Tavernese, Annamaria
Musolino, Vincenzo
Carresi, Cristina
Maiuolo, Jessica
Muscoli, Carolina
Tomino, Carlo
Rosano, Giuseppe Maria
Fini, Massimo
Volterrani, Maurizio
Silvestrini, Bruno
Mollace, Vincenzo
PHARMACEUTICS, 2022, 14 (01)
[42] Design of Reach: Phase 3 randomized, double-blind, placebo-controlled, 48-week study of the efficacy and safety of losmapimod in FSHD
Tawil, R.
Han, J.
Wang, L.
Vissing, J.
van Engelen, B.
Statland, J.
Mellion, M.
Shoskes, J.
Morabito, C.
Jiang, J.
Webster, J.
NEUROMUSCULAR DISORDERS, 2022, 32 : S104 - S104
[43] A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of lacosamide in subjects with painful distal diabetic neuropathy
Wymer, J
Garrison, C
Simpson, J
Koch, B
NEUROLOGY, 2006, 66 (05) : A202 - A202
[44] A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
Nyhlin, H
Bang, C
Elsborg, L
Silvennoinen, J
Holme, I
Rüegg, P
Jones, J
Wagner, A
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (02) : 119 - 126
[45] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
Robert Bissonnette
Catherine Maari
Athanasios Tsianakas
DeAnne Reid
Sara McCutchan
Scott Baumgartner
James Mackay
Nihar Bhakta
Dermatology and Therapy, 2021, 11 : 2179 - 2193
[46] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
Bissonnette, Robert
Maari, Catherine
Tsianakas, Athanasios
Reid, DeAnne
McCutchan, Sara
Baumgartner, Scott
Mackay, James
Bhakta, Nihar
DERMATOLOGY AND THERAPY, 2021, 11 (06) : 2179 - 2193
[47] THE SAFETY AND TOLERABILITY OF LACOSAMIDE IN RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II/III CLINICAL TRIALS
Gil-Nagel, A.
Biton, V.
Fountain, N.
Rosenow, F.
Hebert, D.
Doty, P.
EPILEPSIA, 2009, 50 : 110 - 110
[48] A phase 2, randomized, placebo-controlled, double-blind, ascending dose study to evaluate efficacy, safety, tolerability, pharmacokinetics, pharmacodynamics & pharmacogenetics of CC-220 in subjects with SLE
Werth, V.
Furie, R.
Hough, D.
Korish, S.
Weiswasser, M.
Azarian, A.
Schafer, P.
Delev, N.
Choi, S.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S65 - S65
[49] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Li, Yi
Toyama, Kaoru
Nakatsu, Takafumi
Ishizuka, Hitoshi
Wu, Hailan
Cao, Guoying
Yu, Jicheng
Wang, Yu
Liu, Xiaofen
Guo, Beining
Wu, Jufang
Yu, Peimin
Hong, Zhen
Zhang, Jing
Wu, Xiaojie
ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
[50] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Yi Li
Kaoru Toyama
Takafumi Nakatsu
Hitoshi Ishizuka
Hailan Wu
Guoying Cao
Jicheng Yu
Yu Wang
Xiaofen Liu
Beining Guo
Jufang Wu
Peimin Yu
Zhen Hong
Jing Zhang
Xiaojie Wu
Advances in Therapy, 2023, 40 (4) : 1628 - 1643

← 1 2 3 4 5 →